Filter
1064
Filtered Results: 1064
Text search:
rifampicina
Featured
Recommendations
127
New Publications
284
Language
Document type
No document type
692
Guidelines
155
Studies & Reports
87
Manuals
54
Strategic & Response Plan
29
Training Material
19
Fact sheets
17
Situation Updates
5
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
58
India
58
Eastern Europe
32
South Africa
25
Nepal
23
Latin America and the Carribbean
22
Kenya
19
Colombia
16
Tanzania
16
Argentina
16
Peru
15
Nigeria
14
Namibia
14
Germany
13
Paraguay
13
Bangladesh
13
Uganda
13
Indonesia
13
Global
12
Ethiopia
12
Zambia
12
El Salvador
11
Rwanda
11
Malawi
10
Bolivia
10
Brazil
10
Philippines
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Ukraine
8
Senegal
7
Mozambique
7
Asia
7
Africa
6
Congo, Democratic Republic of
6
Russia
6
Tajikistan
5
Cameroon
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Benin
4
Chile
4
Venezuela
4
Botswana
4
Lesotho
3
Ghana
3
Sierra Leone
3
Burkina Faso
3
Zimbabwe
3
Georgia
3
Bhutan
3
Madagascar
3
Pakistan
3
Timor Leste/ East Timor
2
Syria
2
Armenia
2
Haiti
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Liberia
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Turkmenistan
1
Tunisia
1
Spain
1
Lebanon
1
Vietnam
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
434
Clinical Guidelines
137
Public Health
22
Women & Child Health
22
Capacity Building
17
Pharmacy & Technologies
14
Key Resources
6
Toolboxes
TB
499
HIV
93
NTDs
48
Pharmacy
36
AMR
34
Refugee
16
Polio
12
COVID-19
8
Ebola
5
Caregiver
5
Mental Health
4
Conflict
4
Global Health Education
3
Rapid Response
2
Natural Hazards
1
Planetary Health
1
Zika
1
Integrated Management of Adolescent and Adult Illness (IMAI)
July 2008
Prise en charge Intégrée des maladies de l’adolescent
et de l’adulte (PCIMAA)
Avril 2007
WHO/HTM/VIH/2007.01
WHO/HTM/TB/2007.380
Version 9.0
Octobre 2017
16.7.2021
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decisions about appropriate treatment for specific clinical...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
Une application importante de la santé numérique dans les soins aux patients atteints de tuberculose est le soutien qu'elle peut apporter à l'observance du traitement. Les programmes de lutte contre la tuberculose utilisent déjà le service de messages courts (SMS), le traitement assisté par v...
Policy brief. July 2020
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
